Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 5 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

5 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Aug. 12, 2024 HHS P 61 $6.96 $425 29,474 Direct +0.21% Acquired -34.5% (price as of 2026-10-02)
Aug. 12, 2024 HHS P 7,082 $7.00 $49,574 29,413 Direct +31.71% Acquired -34.9% (price as of 2026-10-02)
May 13, 2024 HHS P 1 $7.08 $7 15,282 Direct +0.01% Acquired -35.6% (price as of 2026-10-02)
May 13, 2024 HHS P 221 $7.07 $1,562 15,503 Direct +1.45% Acquired -35.5% (price as of 2026-10-02)
May 13, 2024 HHS P 400 $7.09 $2,836 15,903 Direct +2.58% Acquired -35.7% (price as of 2026-10-02)
May 13, 2024 HHS P 6,000 $7.10 $42,600 21,903 Direct +37.73% Acquired -35.8% (price as of 2026-10-02)
May 13, 2024 HHS P 300 $7.00 $2,100 22,203 Direct +1.37% Acquired -34.9% (price as of 2026-10-02)
May 13, 2024 HHS P 1 $6.99 $7 22,204 Direct 0.00% Acquired -34.8% (price as of 2026-10-02)
May 13, 2024 HHS P 127 $7.01 $890 22,331 Direct +0.57% Acquired -35.0% (price as of 2026-10-02)
Nov. 15, 2023 HHS P 3,500 $7.09 $24,815 13,042 Direct +36.68% Acquired -35.7% (price as of 2026-10-02)
Nov. 15, 2023 HHS P 1,223 $7.08 $8,659 14,265 Direct +9.38% Acquired -35.6% (price as of 2026-10-02)
Nov. 15, 2023 HHS P 50 $6.98 $349 14,315 Direct +0.35% Acquired -34.7% (price as of 2026-10-02)
Nov. 15, 2023 HHS P 400 $6.97 $2,788 14,715 Direct +2.79% Acquired -34.6% (price as of 2026-10-02)
Nov. 15, 2023 HHS P 400 $6.96 $2,784 15,115 Direct +2.72% Acquired -34.5% (price as of 2026-10-02)
Nov. 15, 2023 HHS P 166 $6.97 $1,157 15,281 Direct +1.10% Acquired -34.6% (price as of 2026-10-02)
Aug. 16, 2023 HHS P 6,700 $5.35 $35,845 6,700 Direct · Acquired -14.8% (price as of 2026-10-02)
Aug. 16, 2023 HHS P 1,000 $5.34 $5,340 7,700 Direct +14.93% Acquired -14.6% (price as of 2026-10-02)
Aug. 16, 2023 HHS P 742 $5.41 $4,014 8,442 Direct +9.64% Acquired -15.7% (price as of 2026-10-02)
Aug. 16, 2023 HHS P 200 $5.24 $1,048 8,642 Direct +2.37% Acquired -13.0% (price as of 2026-10-02)
Aug. 16, 2023 HHS P 900 $5.23 $4,707 9,542 Direct +10.41% Acquired -12.8% (price as of 2026-10-02)
Nov. 8, 2018 TDAY P 6,750 $14.20 $95,850 147,662 Direct +4.79% Acquired -50.4% (price as of 2026-10-02)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
Aug. 14, 2023 HHS Options Common Stock (240,000) $5.59 Aug. 13, 2033 240,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 2 holdings

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
March 19, 2014 TDAY Common Stock Warrants (right to buy) [F1]→ Common Stock · Direct
Jan. 30, 2014 TDAY No securities beneficially owned 0 Direct

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

HHS

Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2025 $73,498 · · · · · · $73,498
2024 $450,000 $243,750 · · · · $13,200 $706,950
2023 $233,654 $293,750 $908,964 · · · $3,462 $1,439,830
Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2019 $507,692 · $850,000 · · $25,234 $1,470,048 $2,852,974
2018 $550,000 $400,000 · · · $0 $3,092 $1,703,092
2017 $550,000 $750,000 $400,000 · · $15,636 $3,231 $1,718,867

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.